Medgend Icon

Ledgend of Medicine







discontinued


Sleeve

Weight loss surgery helps people with extreme obesity to lose weight. It may be an option if you cannot lose weight through diet and exercise or have serious health problems caused by obesity.

There are different types of weight loss surgery. They often limit the amount of food you can take in. Some types of surgery also affect how you digest food and absorb nutrients. All types have risks and complications, such as infections, hernias, and blood clots.

Many people who have the surgery lose weight quickly, but regain some weight later on. If you follow diet and exercise recommendations, you can keep most of the weight off. You will also need medical follow-up for the rest of your life.

NIH: National Institute of Diabetes and Digestive and Kidney Diseases

Sleeve FDA Approved Drugs

APIDRA [Insulin Glulisine Recombinant]
RX
-
1000 units/10ml (100 units/ml) (iv (infusion), subcutaneous injectable)
300 units/3ml (100 units/ml) (iv (infusion), subcutaneous injectable)
Sanofi Aventis UsApr 16, 2004
  • Improvement in glycemic control in diabetes mellitus patients by use of a pen injector with a threaded drive sleeve.
  • Method of treating a patient suffering from diabetes mellitus.
efficacy
1.0  (1)
side effects
0.0  (0)
danger
0.0  (0)

UNK

APIDRA SOLOSTAR [Insulin Glulisine Recombinant]
RX
-
300 units/3ml (subcutaneous injectable)
Sanofi Aventis UsFeb 24, 2009
  • Improvement in glycemic control in diabetes mellitus patients by use of a pen injector with a threaded drive sleeve.
  • Method of treating a patient suffering from diabetes mellitus.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

LANTUS [Insulin Glargine Recombinant]
RX
-
100 units/ml (injection injectable)
Sanofi Aventis UsApr 20, 2000
  • Improvement in glycemic control in diabetes mellitus patients by use of a pen injector with a threaded drive sleeve.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

LANTUS SOLOSTAR [Insulin Glargine Recombinant]
RX
-
300 units/3ml (100 units/ml) (injection injectable)
Sanofi Aventis UsApr 27, 2007
  • Improvement in glycemic control in diabetes mellitus patients by use of a pen injector with a threaded drive sleeve.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

SOLIQUA 100/33 [Insulin GlargineC267H404N72O78S6 : Lixisenatide]
RX
-
300 units/3ml : 99mcg/3ml (100 units/ml : 33mcg/ml) (subcutaneous solution)
Sanofi-aventis UsNov 21, 2016
  • Improvement in glycemic control in adults with type 2 diabetes mellitus inadequately controlled by basal insulin or lixisenatide by use of a pen injector with a threaded drive sleeve.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

TOUJEO SOLOSTAR [Insulin Glargine Recombinant]
RX
-
300 units/ml (300 units/ml) (subcutaneous solution)
Sanofi Us ServicesFeb 25, 2015
  • Improvement in glycemic control in diabetes mellitus patients by use of a pen injector with a threaded drive sleeve.
  • Improvement in glycemic control in diabetes mellitus patients.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.